Gan-du-qing attenuates PM2.5-induced Chronic Airway Inflammation via regulating the pulmonary microbiota and metabolic profiles
Our research offers valuable insights into how GDQ operates to mitigate PM<sub>2.5</sub>-induced lung injury through the modulation of lung microbiota and serum metabolome. These findings may have important implications for the development of effective strategies to protect against lung injury caused by PM<sub>2.5</sub>.
Authors
- Yilan Wang (ORCID: https://orcid.org/0000-0002-8230-4176)
- Sijing Zhao (ORCID: https://orcid.org/0000-0002-4768-6527)
- Yongcan Wu (ORCID: https://orcid.org/0000-0002-0936-0737)
- Biao Zuo
- Demei Huang (ORCID: https://orcid.org/0000-0001-7802-3104)
- Shihua Shi (ORCID: https://orcid.org/0000-0001-6475-2349)
- Zherui Shen (ORCID: https://orcid.org/0000-0003-3483-9552)
- Zhenxing Wang (ORCID: https://orcid.org/0000-0001-6832-9652)
- Xiaomin Wang (ORCID: https://orcid.org/0000-0003-1274-224X)
- Jianwei Wang (ORCID: https://orcid.org/0000-0002-1116-4559)
- Fei Wang (ORCID: https://orcid.org/0000-0003-3630-8819)
- Caixia Pei (ORCID: https://orcid.org/0000-0002-7475-6594)
- Xin Zhou (ORCID: https://orcid.org/0000-0002-9011-0662)
Institutions
- First People's Hospital of Chongqing (CN)
Publication Details
- Journal
- Frontiers in Medicine
- Published
- 2025-09-10
- DOI
- https://doi.org/10.3389/fmed.2025.1560225
- Primary Topic
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Chengdu University of Traditional Chinese Medicine
- Chengdu Science and Technology Bureau
- Chengdu University
- National Key Research and Development Program of China